Dr. Charles brings over 20 years of experience in immunology-focused pharmaceutical development, academic research, and clinical medicine to the role. He joins Climb Bio from Bristol Myers Squibb (BMS), where he held clinical roles of increasing responsibility since joining in 2015, leading the development of numerous therapeutic candidates through IND, Phase 1-4 clinical trials, and FDA product approval. Dr. Charles most recently served as Vice President and Senior Global Program Lead, Immunology at BMS, w ...

REDWOOD CITY, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. ("Biomea," "Biomea Fusion" or the "Company") (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced new preclinical findings from a 28-day weight loss study in obese non-human primates evaluating BMF-650, the Company's investigational, next-generation oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). About BMF-650 BMF-650 is an investigational, next-generation oral small-molec ...

TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi Medical" or the "Company"), is pleased to invite investors and other interested parties to attend the Company's upcoming live webinar presentation, audience Q&A and interview. CEO Tom Looby will discuss Conavi's unique and market-leading imaging technology for minimally invasive cardiovascular procedures. The webinar will be a live, interactive online event where attendees can ask the presenters questions in ...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ROUYN-NORANDA, Quebec, June 18, 2025 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. ("Abcourt" or the "Corporation") (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce that it intends to complete a non-brokered private placement of a secured convertible debenture of the Corporation (the "Debenture") for gross proceeds of $3,000,000 (the "Debenture Offering"). Debenture Offering Concurrently with the closing of the Debenture ...

DENVER, June 18, 2025 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced it will report financial results for the thirteen week period ended May 31, 2025, on Thursday, July 10, 2025, before market open. The Company will host a conference call to discuss these results with additional comments and details provided at that time. Participating on the call wil ...

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Digital Brands Group, Inc. (OTCQX: DBGI), a company specializing in eCommerce, fashion, and luxury lifestyle brands, has qualified to trade on the OTCQX® Best Market. Digital Brands Group, Inc. upgraded to OTCQX from the Pink® market. Digital Brands Group, Inc. begins trading today on OTCQX under the symbol “DBGI.” U.S. investor ...

Fractyl has built its patent portfolio since 2011, and its IP estate now includes 31 granted U.S. patents and approximately 40 pending U.S. applications, along with numerous foreign issued patents and pending applications. The two newly issued patents further reinforce the Company's leadership position in duodenal resurfacing applications. U.S. Patent No. 12,329,439, issued June 17, 2025, and U.S. Patent No. 12,303,185, issued May 20, 2025, both titled "Electrical energy ablation systems, devices and method ...

This announcement is neither an offer to sell nor a solicitation of an offer to buy any of these securities (including the shares of common stock, if any, into which the notes are convertible), nor shall there be any offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under applicable securities laws. ROCK HILL, S.C., June 18, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that it has entered int ...

GONZALES, La., June 18, 2025 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today announced that it intends to release the results of its operations for the fourth quarter and full year of fiscal 2025 before the market opens on Wednesday, June 25, 2025. Olivia W. Elliott, President and Chief Executive Officer, Craig J. Demarest, Vice President and Chief Financial Officer, and Claire K. Spencer, Vice President, will host a teleconference at 8:00 a.m. Central Daylight Time on that da ...

Core Viewpoint - ARRAY Technologies has announced the acquisition of APA Solar, enhancing its capabilities in engineered foundation solutions and fixed-tilt mounting systems for solar projects, which is expected to be accretive to its Adjusted EPS in the first year before synergies [1][4]. Acquisition Details - The acquisition transaction values APA at approximately $179 million, representing a multiple of 7.6x trailing 12 months EBITDA, excluding 45X credits [3][4]. - APA generated approximately $129 million in revenue and $25 million in EBITDA in 2024, excluding 45X credits [1]. - The deal includes $168 million in upfront cash consideration and $42 million in deferred consideration, with $31 million of net present value of tax benefits factored in [3][4]. Strategic Benefits - The acquisition allows ARRAY to offer an integrated tracker and foundation system, addressing challenging soil conditions without the need for specialized installation equipment [2][4]. - The addition of domestically manufactured engineered foundations and fixed-tilt solutions expands ARRAY's addressable market by nearly 40% [4]. - The partnership is expected to enhance operational excellence and provide expanded resources and expertise for both companies [3][6]. Management and Operations - Following the acquisition, APA's senior management team will remain in place and lead the new "Foundation Solutions Business" within ARRAY [6]. - The headquarters and principal manufacturing operations of APA will continue to be located in Ridgeville Corners, Ohio [6]. Timeline and Conditions - The transaction is expected to close in the third quarter of 2025, pending regulatory approvals and customary closing conditions [4][7].